Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX Code: PBT) covers the month of September 2013, specifically dated September 11, 2013. The registrant is a foreign private issuer based in Parkville, Victoria, Australia. The filing serves as a cleansing notice under Section 708A(5) of the Corporations Act 2001 (Cth) regarding a recent share issuance.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a capital event:
- Shares Issued: 523,120 Ordinary Fully Paid Shares.
- Issue Date: September 11, 2013.
- Total Proceeds: AUD$292,164.
- Disclosure Status: Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act.
Material Changes
The primary material change reported is the increase in the company's share capital through the issuance of 523,120 new ordinary shares. The filing confirms that as of the notice date, the company has complied with Chapter 2M of the Corporations Act and Section 674, and there is no "excluded information" required to be disclosed.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a statutory compliance notice confirming the legal standing of the share issuance and the absence of undisclosed material information.
Investor Verification Checklist
- Verify the total number of shares issued (523,120) and the aggregate value (AUD$292,164) against the company's updated capitalization table.
- Confirm the compliance status of the issuance under Section 708A of the Corporations Act 2001.
- Note that this filing does not contain operational or financial performance data for the period.